Vascular endothelial growth factor expression by hyalocytes and its regulation by glucocorticoid

British Journal of Ophthalmology

Volumn 92, Issue 11, 2008, Pages 1540-1544

  Hata, Y ^a   Sassa, Y ^a   Kita, T ^a   Miura, M ^a   Kano, K ^a   Kawahara, S ^a   Arita, R ^a   Nakao, S ^a   Shih, J L ^b   Ishibashi, T ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b JOSLIN DIABETES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DRUG INHIBITION; HYPOXIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STABILITY; SIGNAL TRANSDUCTION; VITREORETINOPATHY;

ANIMALS; CATTLE; CELL HYPOXIA; DEXAMETHASONE; DNA; GLUCOCORTICOIDS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VITREOUS BODY;

EID: 55449100169     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjo.2008.141002     Document Type: Article

References (21)

1. Noda Y, Hata Y, Hisatomi T, et al. Functional properties of hyalocytes under PDGF-rich conditions. Invest Ophthalmol Vis Sci 2004;45:2107-14.
2. Hirayama K, Hata Y, Noda Y, et al. The involvement of the rho-kinase pathway and its regulation in cytokine-induced collagen gel contraction by hyalocytes. Invest Ophthalmol Vis Sci 2004;45:3896- 903.
3. Ogawa K. Scanning electron microscopic study of hyalocytes in the guinea pig eye. Arch Histol Cytol 2002;65:263-8.
4. Robbins SG, Mixon RN, Wilson DJ, et al. Platelet-derived growth factor ligands and receptors immunolocalized in proliferative retinal diseases. Invest Ophthalmol Vis Sci 1994;35:3649-63.
5. Bouton M, Gregor Z, McLeod D, et al. Intravitreal growth factors in proliferative diabetic retinopathy: correlation with neovascular activity and glycaemic management. Br J Ophthalmol 1997;81:228-33.
6. Pfeiffer A, Spranger J, Meyer-Schwickerath R, et al. Growth factor alterations in advanced diabetic retinopathy: a possible role of blood retina barrier breakdown. Diabetes 1997;46(2 Suppl):26-30S.
7. Connor TB Jr, Roberts AB, Sporn MB, et al. Correlation of fibrosis and transforming growth factor-beta type 2 levels in the eye. J Clin Invest 1989;83:1661-6.
8. Hackett SF, Campochiaro PA. Implication of protein carboxymethylation in retinal pigment epithelial cell chemotaxis. Ophthalmic Res 1988;20:54-9.
9. Kita T, Hata Y, Miura M, et al. Functional characteristics of connective tissue growth factor on vitreoretinal cells. Diabetes 2007;56:1421-8.
10. Forsythe JA, Jiang BH, Iyer NV, et al. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 1996;16:4604-13.
11. Forooghian F, Razavi R, Timms L. Hypoxia-inducible factor expression in human RPE cells. Br J Ophthalmol 2007;91:1406-10.
12. Kallio PJ, Wilson WJ, O'Brien S, et al. Regulation of the hypoxia-inducible transcription factor 1alpha by the ubiquitin-proteasome pathway. J Biol Chem 1999;274:6519-25.
13. Hellwig-Burgel T, Rutkowski K, Metzen E, et al. Interleukin-1beta and tumor necrosis factor-alpha stimulate DNA binding of hypoxia-inducible factor-1. Blood 1999;94:1561-7.
14. Nakao S, Hata Y, Miura M, et al. Dexamethasone inhibits interleukin-1 beta-induced corneal neovascularization: role of nuclear factor-kappaB-activated stromal cells in inflammatory angiogenesis. Am J Pathol 2007;171:1058-65.
15. Aiello LP, Avery RL, Arrigg PG, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994;331:1480-7.
16. Hata Y, Nakagawa K, Ishibashi T, et al. Hypoxia-induced expression of vascular endothelial growth factor by retinal glial cells promotes in vitro angiogenesis. Virchows Arch 1995;426:479-86.
17. Sueishi K, Hata Y, Murata T, et al. Endothelial and glial cell interaction in diabetic retinopathy via the function of vascular endothelial growth factor (VEGF). Pol J Pharmacol 1996;48:307-16.
18. Suzuma I, Hata Y, Clermont A, et al. Cyclic stretch and hypertension induce retinal expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2: potential mechanisms for exacerbation of diabetic retinopathy by hypertension. Diabetes 2001;50:444-54.
19. Suzuma I, Suzuma K, Ueki K, et al. Stretch-induced retinal vascular endothelial growth factor expression is mediated by phosphatidylinositol 3-kinase and protein kinase C (PKC)-zeta but not by stretch-induced ERK1/2, Akt, Ras, or classical/novel PKC pathways. J Biol Chem 2002;277:1047-57.
20. Sakamoto T. Cell biology of hyalocytes [discussion 883]. Nippon Ganka Gakkai Zasshi 2003;107:866-82.
21. Kodama T, Shimizu N, Yoshikawa N, et al. Role of the glucocorticoid receptor for regulation of hypoxia-dependent gene expression. Please cite the above paper and discuss about the difference. J Biol Chem 2003;278:33384-91.